AstraZeneca PLC (AZN) vs Welltower Inc. (WELL)
AZN leads on 11 of 14 compared metrics.
A side-by-side comparison of AstraZeneca PLC and Welltower Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs WELL
growth of $100 · last 30yAZN +732.9%WELL +938.4%WELL compounded faster
AZN WELL
AZN vs WELL: by the numbers
- •AZN is the larger company ($277.22B vs $151.23B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 106.58 P/E).
- •AZN converts more revenue to profit (17.19% vs 12.15% net margin).
- •WELL grew revenue faster over the past five years (21.49% vs 16.99% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 1.38%).
Which is better, AZN or WELL?
Metric tally: AZN 11 · WELL 3It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthWELL(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | WELL |
|---|---|---|
| P/E ratio | 26.92● | 106.58 |
| Forward P/E | 15.33● | 73.96 |
| P/S ratio | 4.62● | 13.43 |
| P/B ratio | 5.90 | 3.55● |
| PEG ratio | 0.14 | — |
| EV / EBITDA | 14.92● | 64.79 |
| FCF yield | 2.89% | — |
Profitability
| Metric | AZN | WELL |
|---|---|---|
| Gross margin | 81.68%● | 38.87% |
| Operating margin | 23.69%● | 4.62% |
| Net margin | 17.19%● | 12.15% |
| ROE | 21.95%● | 3.21% |
| ROIC | 13.03%● | 0.54% |
Dividends
| Metric | AZN | WELL |
|---|---|---|
| Dividend yield | 1.79%● | 1.38% |
| Payout ratio | 48.48% | 209.93% |
Growth (annualized)
| Metric | AZN | WELL |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 21.49%● |
| EPS CAGR (5Y) | 22.02%● | -9.79% |
| FCF CAGR (5Y) | 15.68% | — |
| Total return CAGR (5Y) | 11.03% | 24.90%● |
Frequently asked
- Which is better, AZN or WELL?
- It depends on your goal. value: AZN (lower P/E); growth: WELL (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 11 to 3.
- Is AZN or WELL cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and WELL at 106.58.
- Which has grown faster, AZN or WELL?
- Over the past five years, WELL grew revenue faster — AZN at a 16.99% CAGR versus WELL at 21.49%.
- Does AZN or WELL pay a bigger dividend?
- AZN yields 1.79% and WELL yields 1.38% based on trailing dividends and the latest price.
- Is AZN or WELL more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus WELL at 12.15%.
- Which has been the better investment, AZN or WELL?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus WELL at 15.57%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioWelltower P/E ratioAstraZeneca dividend yieldWelltower dividend yieldAstraZeneca ROEWelltower ROEAstraZeneca operating marginWelltower operating marginAstraZeneca revenue growthWelltower revenue growthAstraZeneca free cash flowWelltower free cash flow
AstraZeneca & Welltower appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.